Alkaline Composition Dissolving Protein Warts With Anesthetic
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for pathological tissues and pathogens, such as neoplasm, malignant hyperplasia, and dermatomycosis, often lack efficacy and are associated with significant side effects, and existing compositions do not effectively dissolve and eliminate these conditions quickly and selectively.
Innovation Solution
A pharmaceutical composition comprising 1.0-60.0 parts of sodium hydroxide or potassium hydroxide, combined with anesthetic compounds like tetracaine and bufalin, and traditional Chinese medicine extracts like isoliquiritigenin, baicalin, berberine, and emodin, which are mixed with water to form a complex preparation that rapidly dissolves and eliminates pathological tissues and pathogens by leveraging the alkaline properties of quicklime.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for pathological tissues and pathogens, then treatment coverage is provided, but efficacy is insufficient and side effects are significant
Solution Approach 1:
The patent changes the chemical parameter by using alkaline substances (sodium hydroxide, potassium hydroxide, or quicklime) with specific pH levels to dissolve protein-based pathological tissues. This parameter change enables effective dissolution of warts, neoplasms, and pathogens while the controlled application minimizes harm to normal tissues, resolving the contradiction between efficacy and side effects
Solution Approach 2:
The patent converts the harmful property of strong alkaline substances into a beneficial therapeutic effect. The caustic nature of sodium hydroxide, potassium hydroxide, or quicklime is harnessed to selectively dissolve pathological tissues and kill pathogens, transforming what would normally be a harmful corrosive effect into a controlled therapeutic mechanism that eliminates disease while preserving healthy tissue through selective application
2Productivity
If existing compositions are applied to pathological tissues, then some therapeutic effect is achieved, but rapid dissolution and elimination is not accomplished
Solution Approach 1:
The patent achieves rapid dissolution by optimizing the concentration and pH parameters of the alkaline solution. By controlling these parameters, the composition dissolves protein-based pathological tissues quickly while maintaining selectivity to avoid damaging surrounding healthy tissues, thus resolving the contradiction between dissolution speed and selectivity
3Reliability
If strong alkaline substances are used to dissolve pathological tissues, then dissolution effectiveness increases, but risk of damaging normal tissues increases
Solution Approach 1:
The patent applies the alkaline composition locally and selectively only to the pathological tissue areas. By controlling the application to affect only the targeted warts, neoplasms, or infected areas while avoiding healthy surrounding tissue, the patent achieves effective dissolution where needed without causing unnecessary damage to normal tissues, resolving the contradiction between dissolution effectiveness and tissue damage risk
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves fast and significant curative effects with low side effects, effectively treating conditions like condyloma acuminatum, skin cancer, and dermatological issues without harming normal tissues, and can be used for various skin and sexually transmitted infections, demonstrating rapid dissolution and healing.
Implementation Method 1
The present invention provides a pharmaceutical composition for use in dissolving and eliminating pathological tissues and pathogens based on folk nostrum and traditional Chinese medicine, especially based on the pharmacological effect of the alkaline property of quicklime
Implementation Method 2
The pharmaceutical composition of the present invention further comprises 0.25-1.0 parts of tetracaine, bufalin, venenum bufonis and/or menthol for having anesthetic effect
Implementation Method 3
0.01-0.5 parts of isoliquiritigen, 0.01-0.5 parts of baicalin, 0.01-0.5 parts of berberine and/or 0.01-0.5 parts of emodin; wherein said pathological tissues and/or pathogens includes at least one selected from the group consisting of condyloma acuminatum (CA), molluscum contagiosum, skin cancer
Data Source
AI summary
A pharmaceutical composition for dissolving and eliminating wart and excrescence consisting of protein is disclosed in the present invention. The pharmaceutical composition comprises (in 100 weight parts) 1.0-60.0 parts of sodium hydroxide and/or potassium hydroxide. The pharmaceutical composition further comprises 0.25-1.0 parts of tetracaine, bufalin, venenum bufonis and/or menthol having local anesthetic effect. The pharmaceutical composition can dissolve and eliminate wart and excrescence consisting of protein immediately and has significant effect and low side effect.